Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction

por Ibrahim, Ayman, Ghaleb, Ramadan, Mansour, Hossam, Hanafy, Amr, Mahmoud, Naggeh M., Abdelfatah Elsharef, Mohamed, Kamal Salama, Mohamed, Elsaughier, Saud M., Abdel-Wahid, Lobna, Embarek Mohamed, Mona, Ibrahim, Ahmed K., Abdel-Galeel, Ahmed
Publicado 2020